We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Clean Genome® E. coli Provides System for DNA and Protein Production

Read time: Less than a minute

In an article published online in Science, researchers from several institutions including the University of Wisconsin, the Biological Research Center of the Hungarian Academy of Sciences and Scarab Genomics, LLC report on a reduced, stable E. coli genome.

Called Clean Genome® E. coli, this genetically engineered strain can replicate DNA that is unclonable in other E. coli strains as well as DNA that is prone to genetic rearrangement.

The Clean Genome strain is designed to provide the stability and genetic backbone required for plasmid replication and protein production, important for research, and medical and industrial applications.

As reported in Science, Scarab Genomics deleted 15% of the E. coli chromosome-DNA that was either not essential or has potentially harmful attributes.

The Clean Genome is the result of a rational design based on knowledge of the DNA code and the biological role of certain genes.

Scarab removed insertion sequences (IS elements), which have a tendency to migrate in the genome, causing gene transfer. As an IS-free strain, the Clean Genome offers genetic stability otherwise unavailable.

The result is an E. coli genome that is simpler, safer and better behaved. Cell viability, growth, plasmid uptake, plasmid yield and protein production in many instances are improved over other commercially available strains.

For synthetic biologists, the Clean Genome serves as the fundamental structure into which they can build complex systems, modifying metabolic pathways with the assurance and stability necessary to produce high value chemicals, pharmaceuticals and engineered biotherapeutics.

The company has already licensed its technology for use in DNA production and is working with several collaborators on various industrial applications.

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.